Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Rahul Sakhuja , James L Januzzi Added: 3 years ago
Introduction With nearly 500,000 new cases per year and direct costs estimated as high as US$38 billion annually, congestive heart failure (CHF) has become a major priority in modern medicine. This crisis will continue to grow as the population ages, thus the discernment of new diagnostic and therapeutic strategies to improve prognosis and reduce costs is critical. The irony is that therapies… View more
Author(s): Rahul Sakhuja , James L Januzzi Added: 3 years ago
Introduction With nearly 500,000 new cases per year and direct costs estimated as high as US$38 billion annually, congestive heart failure (CHF) has become a major priority in modern medicine. This crisis will continue to grow as the population ages, thus the discernment of new diagnostic and therapeutic strategies to improve prognosis and reduce costs is critical.1 The irony is that therapies… View more
Author(s): John GF Cleland Added: 11 months ago
ESC-HFA 2023 – Prof John Cleland (University of Glasgow, Glasgow, UK) discusses the findings from a study that looked at the diagnostic of heart failure in a cohort of 1.1 million people using the NHS EMR database. Finding presented at Heart Failure 2023, showed that more people treated with LD than receive diagnosis of heart failure, this disparity was greater in women compared to men. … View more
Author(s): Paolo Della Bella Added: 2 years ago
In this short interview from ACC.22, Dr Paolo Della Bella (San Raffaele University-Hospital, IT) joins us to discuss the findings of the PARTITA trial (NCT01547208). The aim of this study was to determine whether the burden of ventricular tachycardia correlates with ICD shock therapies and if the timing of VT ablation affects patient prognosis. Discussion Points: Rationale behind this trial … View more
Job title: Professor of Medicine
Dr Weber is Professor of Medicine and Associate Dean for Research at the SUNY Downstate College of Medicine in Brooklyn, New York. He received his medical degree from Sydney University in Australia.His career has been focused primarily on hypertension and preventive cardiology. Dr Weber was one of the founders of The American Society of Hypertension and has served as its President. He is a… View more
Job title: Associate Professor
Dr John Eikelboom is an Associate Professor in the Department of Medicine at McMaster University in Hamilton , Ontario . Dr Eikelboom earned his MBBS degree at the University of Western Australia Medical School, Australia and he completed training in Internal Medicine and Haematology at Royal Perth Hospital , Australia and trained in Epidemiology and Thrombosis Medicine at McMaster University … View more
Job title: Professor, Principal Investigator, Senior Consultant Physician/Cardiologist
Professor Michael Fu is currently a nucleus member of working group of heart failure with preserved ejection fraction, Heart Failure Association, European Society of Cardiology, and an nucleus member of the National Working Group of Heart Failure in Sweden. Michael Fu is an expert in heart failure with research focus on epidemiology, clinical phenotype, prognosis and its risk factors,… View more
Author(s): Carl J Lavie , Richard V Milani Added: 3 years ago
The potential benefits of formal, phase II cardiac rehabilitation and exercise training (CRET) programs have recently been reviewed in great detail.1–3 However, despite the substantial proven benefits of this therapy, which are outlined in part in this review, recent data have emphasized that many patients are not referred to formal CRET,4 and a minority of patients (14% of patients with acute… View more
Dr Ileana L Pina is Professor at the Department of Medicine (Cardiology) and Professor in the Department of Epidemiology and Population Health at Montefiore Einstein Center for Heart and Vascular Care, US. Dr Piña has a particular research and clinical interest in rehabilitation of heart disease in patients with heart failure. She completed a NHLBI HF ACTION trial and is in the process of… View more